Showing results (41-50 of 65) with videos related to

Sort By:
Pageof 7
European Journal of Nuclear Medicine and Molecular Imaging|June 5, 2016
TLG-S criteria are superior to both EORTC and PERCIST for predicting outcomes in patients with metastatic lung adenocarcinoma treated with erlotinibKung-Chu Ho, Yu-Hua Dean Fang, Hsiao-Wen Chung, et al.
Huan Jing Ke Xue= Huanjing Kexue|October 28, 2021
[Characteristics of Industrial Volatile Organic Compounds(VOCs) Emission in China from 2011 to 2019]Rui-Yuan Liu, Mei-Fang Zhong, Xiao-Ya Zhao, et al.
Japanese Journal of Clinical Oncology|December 7, 2014
Cytoplasmic and nuclear parathyroid hormone-related proteins are opposing prognostic factors in patients with non-small-cell lung cancer who have undergone curative resectionChiao-En Wu, Chi-Wei Wang, Wen-Kuan Huang, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|April 11, 2017
Changes in serum α-fetoprotein level predicts treatment response and survival in hepatocellular carcinoma patients and literature reviewWen-Chi Chou, Chia-Lin Lee, Tsai-Sheng Yang, et al.
Anticancer Research|April 30, 2014
Outcomes of patients with metastatic cervical cancer in a phase I clinical trials programMing-Mo Hou, Xiaochun Liu, Jennifer Wheler, et al.
Gynecologic Oncology Research and Practice|May 28, 2016
Characteristics and outcomes for patients with advanced vaginal or vulvar cancer referred to a phase I clinical trials program: the MD Anderson cancer center experienceSiqing Fu, Naiyi Shi, Jennifer Wheler, et al.
Cancer Immunology, Immunotherapy : CII|April 28, 2026
AdvanTIG-206: a phase II, randomized study of ociperlimab plus tislelizumab and BAT1706 (bevacizumab biosimilar) versus tislelizumab and BAT1706 in first-line hepatocellular carcinomaZhenggang Ren, Yao Huang, Yabing Guo, et al.
Melanoma Research|September 15, 2009
Immunotherapy with dendritic cells pulsed by autologous dactinomycin-induced melanoma apoptotic bodies for patients with malignant melanomaJohn W C Chang, Jia-Juan Hsieh, Yung-Chi Shen, et al.
Oncotarget|May 6, 2016
Continuous anti-angiogenic therapy after tumor progression in patients with recurrent high-grade epithelial ovarian cancer: phase I trial experienceMing-Mo Hou, Zhijie Wang, Filip Janku, et al.
Asia-Pacific Journal of Clinical Oncology|May 23, 2022
Safety and effectiveness of transdermal buprenorphine in cancer pain: An observational study in Taiwan (SOOTHE)Tai-Lin Huang, Yen-Min Huang, Min-Mo Hou, et al.
Pageof 7